← Leaderboards
Stephen M Strittmatter
Yale University
$76,187,371
Attributed
$96,778,116
Total exposure
37
Grants
28
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.8M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$125,817,845 · 39
By mechanism
R01$33,928,450 · 12
P30$26,095,905 · 5
RF1$11,882,376 · 4
U01$10,959,776 · 3
P50$10,510,490 · 3
UH3$8,497,621 · 1
Top collaborators
- Christopher H Van Dyck9 shared
- Marc Hammarlund5 shared
- Sreeganga S Chandra3 shared
- Erik C Gunther3 shared
- Anita Juliane Huttner3 shared
- George Daniel Maynard3 shared
- Haakon Berge Nygaard3 shared
- Nenad Sestan3 shared
Most similar at Yale University
Same institution · by research overlap
- William C. Sessa$34,897,684
- Leonard K Kaczmarek$20,168,615
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuronsPathway InteractionsBrainMolecularS DiseaseCellsSynapsesSignal TransductionReceptorMonitorGenesIn VivoBaseAxonProteinsGeneticPlayPhenotypePathologyDementiaFunctional DisorderComplexLink
Grant awards (153)
Yale Alzheimer Disease Research Center$4,760,911
P30 · FY2025 · AG · contact PI
Molecular Diversity Among Hippocampal and Entorhinal Cells in Aging and Alzheimer's Disease$1,536,271
R01 · FY2025 · AG
Administrative Core$1,126,540
P30 · FY2025 · AG · contact PI
Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's disease$833,826
R01 · FY2025 · NS
mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease$785,885
R01 · FY2025 · AG · contact PI
Synaptic selectivity for microglial-mediated damage in Alzheimer's Disease$781,756
R01 · FY2025 · AG · contact PI
Multimodal Delineation of Neurodegenerative Mechanisms$360,654
T32 · FY2025 · NS · contact PI
IPSC Core$360,123
P30 · FY2025 · AG · contact PI
Yale Alzheimer Disease Research Center$3,170,528
P30 · FY2024 · AG · contact PI
Molecular Diversity Among Hippocampal and Entorhinal Cells in Aging and Alzheimer's Disease$1,589,662
R01 · FY2024 · AG
Genome-Wide Discovery and Translational Research for Neural Repair$1,013,487
R35 · FY2024 · NS · contact PI
mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease$801,923
R01 · FY2024 · AG · contact PI
Synaptic selectivity for microglial-mediated damage in Alzheimer's Disease$797,710
R01 · FY2024 · AG · contact PI
Administrative Core$526,571
P30 · FY2024 · AG · contact PI
Multimodal Delineation of Neurodegenerative Mechanisms$368,999
T32 · FY2024 · NS · contact PI
Yale Alzheimer Disease Research Center$3,182,375
P30 · FY2023 · AG · contact PI
Genome-Wide Discovery and Translational Research for Neural Repair$1,044,835
R35 · FY2023 · NS · contact PI
mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease$801,923
R01 · FY2023 · AG · contact PI
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP$775,259
R01 · FY2023 · AG · contact PI
Administrative Core$460,627
P30 · FY2023 · AG · contact PI
Multimodal Delineation of Neurodegenerative Mechanisms$161,429
T32 · FY2023 · NS · contact PI
Yale Alzheimer Disease Research Center$3,193,057
P30 · FY2022 · AG · contact PI
Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's disease$2,503,003
RF1 · FY2022 · NS
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease$1,657,037
U01 · FY2022 · AG · contact PI
Sex-Specific Single Cell Expression Profiles, Genetic Risk and Drug Responsiveness in Alzheimer's Disease$1,255,677
R56 · FY2022 · AG · contact PI
Genome-Wide Discovery and Translational Research for Neural Repair$1,044,835
R35 · FY2022 · NS · contact PI
mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease$827,048
R01 · FY2022 · AG · contact PI
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP$775,259
R01 · FY2022 · AG · contact PI
Administrative Core$460,626
P30 · FY2022 · AG · contact PI
Molecular Diversity Among Hippocampal and Entorhinal Cells in Aging and Alzheimer's Disease$4,896,138
RF1 · FY2021 · AG
Yale Alzheimer Disease Research Center$3,203,339
P30 · FY2021 · AG · contact PI
Synaptic selectivity for microglial-mediated damage in Alzheimer's Disease$2,393,130
RF1 · FY2021 · AG · contact PI
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease$1,667,255
U01 · FY2021 · AG · contact PI
Sex-Specific Single Cell Expression Profiles, Genetic Risk and Drug Responsiveness in Alzheimer's Disease$1,255,679
R56 · FY2021 · AG · contact PI
Genome-Wide Discovery and Translational Research for Neural Repair$1,044,833
R35 · FY2021 · NS · contact PI
mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease$835,423
R01 · FY2021 · AG · contact PI
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP$775,259
R01 · FY2021 · AG · contact PI
Administrative Core$460,625
P30 · FY2021 · AG · contact PI
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease$268,454
U01 · FY2021 · AG · contact PI
Yale Alzheimer Disease Research Center$3,205,958
P30 · FY2020 · AG · contact PI
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease$1,616,066
U01 · FY2020 · AG · contact PI
Genome-Wide Discovery and Translational Research for Neural Repair$1,044,907
R35 · FY2020 · NS · contact PI
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP$775,259
R01 · FY2020 · AG · contact PI
Mechanisms of A-Beta Oligomer Induced Synapse Dysfunction in Alzheimerâs Disease$616,211
R01 · FY2020 · AG · contact PI
Administrative Core$460,625
P30 · FY2020 · AG · contact PI
Evaluation of Novel Axon Regeneration Targets for Spinal Cord injury Therapy$253,571
R01 · FY2020 · NS
Yale Alzheimer Disease Research Center$1,665,000
P50 · FY2019 · AG · contact PI
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease$1,657,941
U01 · FY2019 · AG · contact PI
Genome-Wide Discovery and Translational Research for Neural Repair$1,044,975
R35 · FY2019 · NS · contact PI
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP$775,259
R01 · FY2019 · AG · contact PI
Mechanisms of A-Beta Oligomer Induced Synapse Dysfunction in Alzheimerâs Disease$616,211
R01 · FY2019 · AG · contact PI
Evaluation of Novel Axon Regeneration Targets for Spinal Cord injury Therapy$253,571
R01 · FY2019 · NS
Adminstrative Core of Yale ADRC$225,063
P50 · FY2019 · AG · contact PI
Aberrant Post-Synaptic Density Function in Alzheimer's Disease$207,128
P50 · FY2019 · AG · contact PI
Yale Alzheimer Disease Research Center$1,665,000
P50 · FY2018 · AG · contact PI
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease$1,646,216
U01 · FY2018 · AG · contact PI
Genome-Wide Discovery and Translational Research for Neural Repair$1,015,652
R35 · FY2018 · NS · contact PI
Evaluation of Novel Targets for Retinal Ganglion Cell Axon Regeneration$681,630
U01 · FY2018 · EY · contact PI
Mechanisms of A-Beta Oligomer Induced Synapse Dysfunction in Alzheimerâs Disease$616,211
R01 · FY2018 · AG · contact PI
Evaluation of Novel Axon Regeneration Targets for Spinal Cord injury Therapy$253,571
R01 · FY2018 · NS
Adminstrative Core of Yale ADRC$226,875
P50 · FY2018 · AG · contact PI
Aberrant Post-Synaptic Density Function in Alzheimer's Disease$208,799
P50 · FY2018 · AG · contact PI
Mechanisms of A-Beta Oligomer Induced Synapse Dysfunction in Alzheimerâs Disease$123,950
R01 · FY2018 · AG · contact PI
Yale Alzheimer Disease Research Center$1,665,000
P50 · FY2017 · AG · contact PI
Genome-Wide Discovery and Translational Research for Neural Repair$850,774
R35 · FY2017 · NS · contact PI
Evaluation of Novel Targets for Retinal Ganglion Cell Axon Regeneration$681,630
U01 · FY2017 · EY · contact PI
Mechanisms of A-Beta Oligomer Induced Synapse Dysfunction in Alzheimerâs Disease$616,211
R01 · FY2017 · AG · contact PI
Evaluation of Novel Axon Regeneration Targets for Spinal Cord injury Therapy$253,571
R01 · FY2017 · NS
Adminstrative Core of Yale ADRC$228,827
P50 · FY2017 · AG · contact PI
Aberrant Post-Synaptic Density Function in Alzheimer's Disease$210,591
P50 · FY2017 · AG · contact PI
Imaging Innate Immune Responsiveness of Microglia in Alzheimer's Disease Brain$209,375
R21 · FY2017 · AG
Fyn Inhibition by AZD0530 for Alzheimers Disease$2,590,082
UH3 · FY2016 · TR · contact PI
Characterizing and Targeting Pyk2 Kinase in Alzheimerâs Disease$2,090,105
RF1 · FY2016 · AG · contact PI
Yale Alzheimer Disease Research Center$1,665,000
P50 · FY2016 · AG · contact PI
Evaluation of Novel Targets for Retinal Ganglion Cell Axon Regeneration$681,630
U01 · FY2016 · EY · contact PI
Mechanisms of A-Beta Oligomer Induced Synapse Dysfunction in Alzheimerâs Disease$615,904
R01 · FY2016 · AG · contact PI
Evaluation of Novel Axon Regeneration Targets for Spinal Cord injury Therapy$382,705
R01 · FY2016 · NS · contact PI
Cortical Plasticity during Recovery from Spinal Cord Injury$364,219
R01 · FY2016 · NS · contact PI
Imaging Innate Immune Responsiveness of Microglia in Alzheimer's Disease Brain$251,250
R21 · FY2016 · AG
Adminstrative Core of Yale ADRC$228,575
P50 · FY2016 · AG · contact PI
Aberrant Post-Synaptic Density Function in Alzheimer's Disease$210,359
P50 · FY2016 · AG · contact PI
Yale Alzheimer Disease Research Center$1,663,561
P50 · FY2015 · AG · contact PI
Progranulin interaction with Sortilin in FrontoTemporal Dementia$364,219
R01 · FY2015 · NS · contact PI
Cortical Plasticity during Recovery from Spinal Cord Injury$364,219
R01 · FY2015 · NS · contact PI
Adminstrative Core of Yale ADRC$229,500
P50 · FY2015 · AG · contact PI
Aberrant Post-Synaptic Density Function in Alzheimer's Disease$211,212
P50 · FY2015 · AG · contact PI
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$1
U01 · FY2015 · AG
Fyn Inhibition by AZD0530 for Alzheimers Disease$5,907,539
UH3 · FY2014 · TR · contact PI
Functional Genomics of Axonal and Synapse Regeneration$643,799
R33 · FY2014 · NS · contact PI
Cortical Plasticity during Recovery from Spinal Cord Injury$360,577
R01 · FY2014 · NS · contact PI
Progranulin interaction with Sortilin in FrontoTemporal Dementia$360,577
R01 · FY2014 · NS · contact PI
Prion Protein in Alzheimer's Disease Pathophysiology$326,111
R01 · FY2014 · AG · contact PI
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$200,958
U01 · FY2014 · AG
Fyn Inhibition by AZD0530 for Alzheimers Disease$2,885,426
UH2 · FY2013 · TR · contact PI
Functional Genomics of Axonal and Synapse Regeneration$778,921
R33 · FY2013 · NS · contact PI
Cortical Plasticity during Recovery from Spinal Cord Injury$351,295
R01 · FY2013 · NS · contact PI
Progranulin interaction with Sortilin in FrontoTemporal Dementia$351,032
R01 · FY2013 · NS · contact PI
Prion Protein in Alzheimer's Disease Pathophysiology$308,174
R01 · FY2013 · AG · contact PI
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$200,958
U01 · FY2013 · AG
Cortical Plasticity during Recovery from Spinal Cord Injury$362,943
R01 · FY2012 · NS · contact PI
Progranulin interaction with Sortilin in FrontoTemporal Dementia$362,670
R01 · FY2012 · NS · contact PI
Prion Protein in Alzheimer's Disease Pathophysiology$326,111
R01 · FY2012 · AG · contact PI
Functional Genomics of Axonal and Synapse Regeneration$324,639
R21 · FY2012 · NS · contact PI
Axonal Growth Cone Signal Transduction$464,610
R37 · FY2011 · NS · contact PI
Progranulin interaction with Sortilin in FrontoTemporal Dementia$362,031
R01 · FY2011 · NS · contact PI
Prion Protein in Alzheimer's Disease Pathophysiology$326,111
R01 · FY2011 · AG · contact PI
Axonal Growth Therapy for Neurological Recovery from Spinal Cord Injury and Strok$3,000,000
RC3 · FY2010 · NS
Yale Cellular Neuroscience, Neurodegeneration and Repair (CNNR) Program$762,000
P30 · FY2010 · NS · contact PI
Molecular Determinants of Adult CNS Axonal Growth$481,949
R01 · FY2010 · NS · contact PI
Axonal Growth Cone Signal Transduction$469,350
R37 · FY2010 · NS · contact PI
Nogo Receptor in Adult Central Nervous System Plasticity and Regeneration$358,412
R01 · FY2010 · NS · contact PI
Prion Protein in Alzheimer's Disease Pathophysiology$339,275
R01 · FY2010 · AG · contact PI
Nogo Receptor Antagonist for Ischemic Stroke Recovery$275,050
R01 · FY2010 · NS · contact PI
Yale Cellular Neuroscience, Neurodegeneration and Repair (CNNR) Program$762,000
P30 · FY2009 · NS · contact PI
Molecular Determinants of Adult CNS Axonal Growth$481,949
R01 · FY2009 · NS · contact PI
Axonal Growth Cone Signal Transduction$474,091
R37 · FY2009 · NS · contact PI
Nogo Receptor in Adult Central Nervous System Plasticity and Regeneration$362,031
R01 · FY2009 · NS · contact PI
Nogo Receptor Antagonist for Ischemic Stroke Recovery$277,827
R01 · FY2009 · NS · contact PI
Nogo Receptor in Adult Central Nervous System Plasticity and Regeneration$361,485
R01 · FY2008 · NS · contact PI
Axonal Growth Cone Signal Transduction$358,502
R37 · FY2008 · NS · contact PI
Molecular Determinants of Axonal Regeneration$358,502
R01 · FY2008 · NS · contact PI
Nogo Receptor Antagonist for Ischemic Stroke Recovery$277,827
R01 · FY2008 · NS · contact PI
Nogo Receptor in Adult Central Nervous System Plasticity and Regeneration$360,938
R01 · FY2007 · NS · contact PI
Molecular Determinants of Axonal Regeneration$358,502
R01 · FY2007 · NS · contact PI
Axonal Growth Cone Signal Transduction$358,502
R37 · FY2007 · NS · contact PI
Oligodendrocyte regulation of axonal morphology in chronic sublethal hypoxia$277,854
P01 · FY2007 · NS · contact PI
Nogo Receptor Antagonist for Ischemic Stroke Recovery$277,827
R01 · FY2007 · NS · contact PI
Molecular Determinants of Axonal Regeneration$369,209
R01 · FY2006 · NS · contact PI
Axonal Growth Cone Signal Transduction$369,209
R37 · FY2006 · NS · contact PI
Oligodendrocyte regulation of axonal morphology$293,038
P01 · FY2006 · NS · contact PI
Nogo Receptor Antagonist for Ischemic Stroke Recovery$286,125
R01 · FY2006 · NS · contact PI
Molecular Determinants of Axonal Regeneration$378,094
R01 · FY2005 · NS
Axonal Growth Cone Signal Transduction$378,094
R37 · FY2005 · NS
Nogo Receptor in Axonal Regeneration$367,875
R01 · FY2005 · NS
Oligodendrocyte regulation of axonal morphology$293,038
P01 · FY2005 · NS
Conference on Axonal Connections$20,000
R13 · FY2005 · NS
AXONAL GROWTH CONE SIGNAL TRANSDUCTION$408,750
R01 · FY2004 · NS
Nogo Receptor in Axonal Regeneration$367,875
R01 · FY2004 · NS
Oligodendrocyte regulation of axonal morphology$293,038
P01 · FY2004 · NS
MOLECULAR DETERMINANTS OF AXONAL REGENERATION$286,125
R01 · FY2004 · NS
AXONAL GROWTH CONE SIGNAL TRANSDUCTION$408,750
R01 · FY2003 · NS
Nogo Receptor in Axonal Regeneration$367,875
R01 · FY2003 · NS
Oligodendrocyte regulation of axonal morphology$293,755
P01 · FY2003 · NS
MOLECULAR DETERMINANTS OF AXONAL REGENERATION$286,125
R01 · FY2003 · NS
AXONAL GROWTH CONE SIGNAL TRANSDUCTION$408,750
R01 · FY2002 · NS
Nogo Receptor in Axonal Regeneration$367,875
R01 · FY2002 · NS
MOLECULAR DETERMINANTS OF AXONAL REGENERATION$286,125
R01 · FY2002 · NS
AXONAL GROWTH CONE SIGNAL TRANSDUCTION$408,750
R01 · FY2001 · NS
Nogo Receptor in Axonal Regeneration$367,875
R01 · FY2001 · NS
MOLECULAR DETERMINANTS OF AXONAL REGENERATION$286,125
R01 · FY2001 · NS
AXONAL GROWTH CONE SIGNAL TRANSDUCTION$408,750
R01 · FY2000 · NS
MOLECULAR DETERMINANTS OF AXONAL REGENERATION$286,125
R01 · FY2000 · NS
MOLECULAR DETERMINANTS OF AXONAL REGENERATION$50,000
R01 · FY2000 · NS